ProPhase Labs, Inc. (PRPH) Social Stream
PROPHASE LABS INC (PRPH) Price Targets From Analysts
Use the tables below to see what analysts covering PROPHASE LABS INC think about its future price and what recommendations they have for investors and traders.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-12 | 1 | $5 | $5 | $5 | $5.1 | -1.96% |
| 2021-12-20 | 2 | $12 | $5 | $8.5 | $5.1 | 66.67% |
| 2022-02-16 | 2 | $15 | $5 | $10 | $5.1 | 96.08% |
| 2022-04-01 | 2 | $16 | $5 | $10.5 | $5.1 | 105.88% |
| 2022-05-16 | 2 | $14 | $5 | $9.5 | $5.1 | 86.27% |
| 2022-08-15 | 2 | $14 | $5 | $9.5 | $5.1 | 86.27% |
| 2023-03-29 | 1 | $15 | $15 | $15 | $5.1 | 194.12% |
| 2023-10-18 | 1 | $14 | $14 | $14 | $5.1 | 174.51% |
| 2023-11-10 | 1 | $11 | $11 | $11 | $5.1 | 115.69% |
The Trend in the Analyst Price Target
Over the past 31 months, PRPH's average price target has gone down $11.5.
Over the past 39 weeks, PRPH's average upside potential has been 112.55%.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2023-02-07 | 1 | 15 | 15 | 15 | 8.21 | 82.7% |
| 2023-02-16 | 1 | 15 | 15 | 15 | 7.64 | 96.34% |
| 2023-05-12 | 1 | 14 | 14 | 14 | 7.93 | 76.54% |
| 2023-06-02 | 1 | 14 | 14 | 14 | 8.58 | 63.17% |
| 2023-11-10 | 1 | 11 | 11 | 11 | 4.55 | 141.76% |
PRPH Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1 | 1 | 0 | 0 | 0 | 0 | 1 |
The Trend in the Broker Recommendations
Over the past 33 months, PRPH's average broker recommendation rating improved by 1.
The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.
- PROPHASE LABS INC's number of analysts covering the stock is greater than 14.15% of all US stocks.
- In terms of how PROPHASE LABS INC fares relative to all US stocks, note that its variance in analysts' estimates is lower than -247% of that group.
- PROPHASE LABS INC's average analyst price target is higher than 150.66% of Healthcare stocks.
- PROPHASE LABS INC's upside potential (average analyst target price relative to current price) is higher than 302.91% of stocks in the micro market cap category.
In the Pharmaceutical Products industry, QLI, FLGC, and DERM are the three stocks most similar to PROPHASE LABS INC regarding the price target and analyst recommendation information presented here.
View All Top Stocks by Price Target
Is PRPH a Buy, Hold or Sell? See the POWR Ratings now!